MedicalSystem Biotechnology (SHE:300439) received a medical device registration certificate from the food and drug administration of China's Zhejiang Province, according to a Shenzhen Stock Exchange disclosure on Friday.

The certificate is for the in vitro diagnostic product manufacturer's antithrombin III detection kit (chromogenic substrate method). It is valid until January 5, 2030, the disclosure added.

The company's shares fell less than 2% in recent trade.